CD4+ T cells, in the presence of TGFβ and IL-10, can differentiate into inducible Treg cells, which are a subset of CD4+ T cells; within different tumors, they suppress antitumor properties of CD4+ and CD8+ T cells leading to poor prognosis and increased tumor growth (152). This evidence concerns the gene TGFB1 and neoplasm.